Showing results (331-340 of 373) with videos related to
Sort By:
Pageof 38
International Journal of Molecular Epidemiology and Genetics|May 24, 2017
Expression of pattern recognition receptor genes and mortality in patients with colorectal adenocarcinomaKathryn E Royse, Liang Chen, David H Berger, et al.Science (New York, N.Y.)|January 24, 2009
The peopling of the Pacific from a bacterial perspectiveYoshan Moodley, Bodo Linz, Yoshio Yamaoka, et al.Public Health Reports (Washington, D.C. : 1974)|May 4, 2010
Hyperendemic H. pylori and tapeworm infections in a U.S.-Mexico border populationVictor M Cardenas, Kristina D Mena, Melchor Ortiz, et al.Human Pathology|December 3, 2014
Differences in interleukin 8 expression in Helicobacter pylori-infected gastric mucosa tissues from patients in Bhutan and the Dominican RepublicHiroyuki Nagashima, Shun Iwatani, Modesto Cruz, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 3, 2018
Equivalent Efficacies of Reverse Hybrid and Bismuth Quadruple Therapies in Eradication of Helicobacter pylori Infection in a Randomized Controlled TrialPing-I Hsu, Feng-Woei Tsay, David Y Graham, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 11, 2012
Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white menJennifer R Kramer, Lori A Fischbach, Peter Richardson, et al.Gut|February 15, 2013
Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control studyHashem B El-Serag, Ali Hashmi, Jose Garcia, et al.Nature|February 9, 2007
An African origin for the intimate association between humans and Helicobacter pyloriBodo Linz, François Balloux, Yoshan Moodley, et al.Alimentary Pharmacology & Therapeutics|April 26, 2019
Randomised controlled trial: susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatmentQi Chen, Xiaohua Long, Yingjie Ji, et al.The Lancet. Gastroenterology & Hepatology|July 26, 2018
Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1/2 studyPeter Malfertheiner, Michael Selgrad, Thomas Wex, et al.Pageof 38